Τόμος 19 (2005) – Τεύχος 1 – Άρθρο 7 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 19 (2005) – Issue 1 – Article 7 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1.       Nursing Department, Educational Technological Institute of Athens, Athens, Greece

2.      Educational Technological Institute of Larissa, Greece

3.      Anticancer Institute Agios Savas, Athens, Greece

4.      Department of Social Services, Bank of Greece, Athens, Greece

5.      Pamakaristos Hospital, Athens, Greece

6.      Nursing Department, University of Athens, Athens, Greece

 Accepted for publication: 8 February 2005

pharmakonpress[at]pharmakonpress[.]gr

2.    Green A., Geal E.A.M., Patterson C.C.: Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 339: 905-909 (1992)

3.    Maclaren N., Atkinson M.: Is insulin-dependent diabetes mellitus environmentally induced? N. Engl. J. Med. 327: 348-349 (1992)

4.    Kostraba J.N.: What can epidemiology tell us about the role of infant diet In the etiology of IDDM? Diabetes Care 17: 87-91 (1994)

5.    Tuomilehto J., Rewers M., Reunanen A., et al.: increasing trend in type I (insulin-dependent) diabetes mellitus in childhood in Finland. Diabetologia 34: 282-287 (1991)

6.    Drykoningen C.E., Mulder A.L, Vaandrager G.L., La Porte R.E., Bruining G.L.: The incidence of male childhood type I (insulin-dependent) diabetes mellitus is rising rapidly in the Netherlands. Diabetologia 35: 139-142 (1992)

7.    Barnett A.H., Eff C., Leslie R.D.G., Pyke D.A.: Diabetes in identical twins: a study of 200 pairs. Diabetologia 20: 87- 93 (1981)

8.    La Porte R.E., Cruickshanks K.J.: Incidence and risk factors for insulin-dependent diabetes. In: National Diabetes Data Group. Diabetes in America: diabetes data compiled 1984. Bethesda, Md: Department of Health and Human Services, 1985: III-1-III-12. (NIH publication no.85 – 1468)

9.    Amiel S.A., Caprio S., Sherwin R.S., Plewe G., Haymond M.W., Tamborlane W.V.: Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J. Clin. Endocrinol. Metab. 72: 277-282 (1991)

10.  World Health Organization, Department of Non-Communicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999

11.  The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197 (1997)

12.  Eisenbarth G.S.: Type l diabetes mellitus: a chronic auto-immune disease. N. Engl. J. Med. 314: 1360-1368 (1989)

13.  Mandrup-Poulsen T., Nerup J.: The auto-immune hypothesis of insulin-dependent diabetes: 1965 to the present. In: Auto-immunity and the Pathogenesis of Diabetes (Ginsberg-Fellner F., McEvoy R.C., eds). Pp. 1-28, Springer-Verlag, New York, 1990

14.  Rossini A.A., Greiner D.L., Friedman H.P., Mordes J.P.: Immunopathogenesis of diabetes mellitus. Diabetes Rev. 1: 43-75 (1993)

15.  Lo S.S.S., Tun R.Y.M., Leslie R.D.G.: Non-genetic factors causing type I diabetes. Diabetic Med. 8: 609-618 (1991)

16.  Nerup J.: Etiology and pathogenesis of insulin-dependent diabetes mellitus: present views and future developments. In: Etiology and Pathogenesis of Insulin-dependent Diabetes Mellitus (Martin J.M., Ehrlich R.M., Holland F.J., eds). Pp. 275-288, Raven Press, New York, 1981

17.  Nerup J., Mandrup-Poulsen T., Hokfelt B.: Genes and gene products in the development of diabetes mellitus. Basic and clinical aspects. Experta Medica, International Congress Series 866, Elsevier, Amsterdam, 1989

18.  Mandrup-Poulsen T., Helqvist S., Wogensen L.D., Pociot F., Johannesen J., Nerup J.: Cytocines and free radicals as effector molecules in the destruction of the pancreatic b-cells. Human Diabetes. II. Environmental and Auto-immune Etiology of b-Cell Destruction, Current topics in Microbiology and Immunology (Baekkeskov S., Hansen B., eds). Pp. 163-193, Springer Verlag, Heidelberg, 1990

19.  Cepts W.: Pathology and anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619-633 (1965)

20.  Lipes M.A., Rosenzweig A., Tan K.N., Tanigawa G., Ladd D., Seidman J.G., Eisenbarth G.S.: Progression to diabetes in nonodese diabetic (NOD) mice with transgenic T cell receptors. Science 259: 1165-1169 (1993)

21.  Hutchings P., Rosen H., O’Reilly L., Simpson E., Gordon S., Cooke A.; Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348: 639-642 (1990)

22.  Bradley B.J., Haskins K., Rosa F.G.L., Lafferty K.: CD 8+ T cells are not required for islet destruction induced by a CD 4+ cell clone. Diabetes 37: 1311-1315 (1988)

23.  Maclaren N., Riley W., Skordis N.: Inherited susceptibility to insulin dependent diabetes is associated with HLA-DR I, while DR5 is protective. Auto-immunity 1: 197-205 (1988)

24.  Fauslman D., Li H.Y.: Linkage of faulty major histocompatibility complex class I to auto-immune diabetes. Science 254: 1756-61 (1991)

25.  Davies J.L., Kawaguchi Y., Bennett S.T.: A genome-wide search for human type I diabetes susceptibility genes. Nature 371: 130-136 (1994)

26.  Dalton T.A., Bennen J.C.: Autoimmune disease, and the major histocompatibility complex: therapeutic implications. Am. J. Med 92: 183-188 (1992)

27. Todd J.A., Bain S.C.: A practical approach to identification of susceptibility genes for IDDM. Diabetes 41: 1029- 1034(1992)

28. Todd J.A.: Genetic control of auto-immunity in type I diabetes. Immunol. Today 11: 122-129 (1990)

29.  Sheehy M.J.: HLA and insulin-dependent diabetes: a protective perspective. Diabetes 41: 123-129 (1992)

30.  Raffel U., Vadheim C.M., Klein R.: HLA-DR and the 5′ insulin gene polymorphism in insulin-dependent diabetes. Metabolism 40: 1244-1248 (1991)

31.  Luocasen A.M., Julier C., Beressi J.-P.: Susceptibility to insulin dependent diabetes melitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat. Genet 4: 305-319 (1993)

32.  Caillat-Zucman S., Berlin E., Timsit J., Boitard C., Assan R., Bach J.-F.: Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur. J. Immunol. 23: 1784-1788 (1993)

33.  Bingley P.J., Bonifacio E., Gale E.A.M.: Can we really predict IDDM? Diabetes 42: 213-220 (1993)

34.  Goodman L.S., Gilman A.: The Pharmacological Basis of Therapeutics. Macmillan. Pp. 1554-1556, New York, 1975

35.  Welsh N., Eizirik D.L., Bendtzen K., Sandler S.: Interleukin-1B-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129: 3167-3173 (1991)

36.  Corbett J.A., Tilton R.G., Chang K., Hasan K.S., Ido Y., Wang J.L., Sweetland M.A., Lancaster J.R.,Jr, Williamson J.R., McDaniel M.L.: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-566 (1992)

37.  Corbett J.A., McDaniel M.L.: Does nitric oxide mediate auto-immune destruction of a-cells? Possible therapeutic interventions in IDDM. Diabetes 41: 897-903 (1992)

38.  Pickup G, Williams G. Textbook of Diabetes. Oxford. England: Blackwell Scientific, 1991.

39.  Foulis A.K., Liddle C.N., Farquharson M.A., Richmond J.A., Weir R.S.: The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in the United Kingdom. Diabetelogia 29: 267-274 (1986)

40.  Rossini A.A., Like A.A., Chick W.L., Appel M.C., Cahill G.F.,Jr.: Studies of streptozotocin-induced insulitis and diabetes. Proc. Nat. Acad. Sci. USA 74: 2485-2489 (1977)

41.  Yamada K., Nonaka K., Hanafusa T., Miyazaki A., Toyoshima H., Tarui S.: Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. Diabetes 31: 749-753 (1982)

42.  Rossini A.A., Mordes J.P., Gallina D.L, Like A.A.: Hormonal and environmental factors in the pathogenesis of BB rat diabetes. Metabolism 32 (Suppl 1): 33-36 (1983)

43.  Mendola G., Casamitjana R., Comis R.: Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetologia 32: 160-162(1989)

44.  Elliott R.B., Chase H.P.: Prevention or delay of type I (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 34: 362-365 (1991)

45.  Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G.F., Gamble D.R: In situ characterization of auto-immune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med 313: 353-360 (1985)

46.  Manna R., Migliore A., Martini L.S., Ponte E., Marietti G., Scuderi F., Cristiano G., Ghirlanda G., Gambassi G.: Nicotinamide treatment in subjects at high risk of developing IDDM improves insulin secretion. Br. J. Clin. Pract. 46: 177-179 (1992)

47.  Dunn J.S., Sheehan H.L., McLetchie N.G.B.: Necrosis of islets of Langerhans produced experimentally. Lancet 1: 484 (1943)

48.  Rerup C.C.: Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22: 485-520 (1970)

49.  Dulin W.E., Soret M.G.: Chemically and hormonally induced diabetes. In: The Diabetic Pancreas (Volk B.W., Wellmann K.F., eds). Pp. 425-466, Balliere Tindall, London, 1977

50.  Mordes J.P., Rossini A.A.: Animal models of diabetes. Am. J. Med. 70: 353-360 (1981)

51.  Rayfield E.J., Ishimura K.: Environmental Factors and insulin-dependent diabetes mellitus. Diabetes/Metab. Rev 3: 925-957(1987)

52.  Burkart V., Koike T., Brenner H.H., Kolb H.: Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro. Diabetologia 35: 1028-1034 (1992)

53.  Dulin W.E., Wyse B.M.: Studies of the ability of compounds to block the diabetogenic activity of streptozotocin. Diabetes 18: 459-466 (1969)

54.  Korsgreen O., Andersson A., Sandler 5: Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 113: 205-214 (1993)

55.  Vague P., Vialettes B., Lassmann-Vague V., Vallo J.J.: Nicotinamide may extend remission phase in insulin-dependent diabetes. Lancet 1: 619-620 (1987)

56.  Vague P., Picq R., Lassmann-Vague V., Vialettes B.: Effect of nicotinamide treatment on the residual insulin secretion in type I (insulin-dependent) diabetic patients. Diabetologia 32: 316-321 (1989)

57.  Herskowitz R.D., Jackson R.A., Soeldner J.S., Eisenbarth G.S: Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide. J. Autoimmun. 2: 733-737(1989)

58.  Papaccio G., Ammendola E.: Nicotinamide decreases MHC class II but not MHC class I expression and increases intercellular adhesion molecule I structures in non-obese diabetic mouse pancreas. J. Endocrinol. 160: 389- 400(1999)

59.  Chakrabarti D., Huang X., Beck J., Henrich J., McFarland N., James R.F.L., Stewart T.A.: Control of islet intercellular adhesion molecule-I expression by interferon-a and hypoxia. Diabetes 45: 1336-1343 (1996)

60.  Eizirik D.L., Sandler S., Welsh N., Bendtzen K., Hellerstrom C.: Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combination of cytokines. Auto-immunity 19: 193-198(1994)

61.  Nicotinamide in NOD mice – G PAPACCIO and others 399, Journal of Endocrinology (1999) 160, 389-400 Hanison LC, Campbell IL, Allison J & Miller JFAP 1989 MHC molecules and A-cell destruction: immune and non-immune mechanisms. Diabetes 38: 815-818, 1999

62.  Manetti R., Annunziato F., Tomasevic L., Gianno V., Parronchi P., Romagnani S., Maggi E.: Polyinosinic acid: polycytidylic acid promotes T helper type I-specific immune responses by stimulating macrophage production of interferon alpha and IL-12. Eur. J. Immunol. 25: 2656-2660 (1995)

63.  Nicoletti F., Zaccone P., Di Marco R., Magro G., Grasso S., Stivala F., Caroli G., Mghini L., Meroni P.L, Garotta G.: Paradoxical anti-diabetogenic effect on a-interferon in DP-BB rats. Diabetes 47: 32-38 (1998)

64.  Lewis C.M., Canafax D.M., Sprafka J.M., Barbosa J.J.: Double-blind randomized trial of nicotinamide on early-onset diabetes. Diabetes Care 15: 121-123 (1992)

65.  Vidal J., Fernande M., Sesmil G., Aguilera E.: Effects of Nicotinamide and Intravenous Insulin Therapy in Newly Diagnosed Type 1 Diabetes. Diabetes Care 23: 360-364 (2000)

66.  Schnell O., Eisfelder B., Standi E., Ziegler A.G.: High dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes 46: 1607- 1611 (1997)

67.  Visalli N., Cacalli M., Signore A., Baroni M.: A multi centered randomized trial of two different doses of nicotinamide in patients with recent onset Type 1 diabetes. Diabetes 15:3 181-185(1999

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr